Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)
Hong Kong · Delayed Price · Currency is HKD 0.7350
-0.0250 (-3.29%)
Oct 9, 2026, 3:59 PM HKT
HKG:3737 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 635 | 484 | 855 | 1,226 | 941 | 855 | |
Market Cap Growth | 14.84% | -43.43% | -30.28% | 30.28% | 10.10% | -39.05% |
Enterprise Value | 528 | 449 | 860 | 1,109 | 806 | 770 |
Last Close Price | 0.73 | 0.56 | 0.94 | 1.30 | 0.88 | 0.80 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 30.28 | 25.14 | 8.44 | 6.84 | 7.83 | 13.36 |
Forward PE | - | 10.30 | 10.30 | 10.30 | 10.30 | 10.30 |
PS Ratio | 0.33 | 0.25 | 0.36 | 0.54 | 0.46 | 0.40 |
PB Ratio | 0.50 | 0.40 | 0.72 | 1.06 | 0.83 | 0.77 |
P/TBV Ratio | 0.50 | 0.40 | 0.73 | 1.08 | 0.85 | 0.79 |
P/FCF Ratio | 3.98 | 3.01 | 19.73 | - | 4.25 | - |
P/OCF Ratio | 3.26 | 2.42 | 4.43 | 10.97 | 2.93 | 3.91 |
PEG Ratio | - | 0.38 | 0.38 | 0.38 | 0.38 | 0.38 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.28 | 0.23 | 0.37 | 0.49 | 0.39 | 0.36 |
EV/EBITDA Ratio | 4.07 | 7.30 | 4.69 | 4.67 | 4.63 | 5.24 |
EV/EBIT Ratio | 33.47 | - | 6.46 | 6.12 | 6.89 | 7.88 |
EV/FCF Ratio | 3.31 | 2.79 | 19.84 | - | 3.63 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.08 | 0.12 | 0.17 | 0.17 | 0.17 | 0.20 |
Debt / EBITDA Ratio | 0.78 | 1.33 | 0.81 | 0.66 | 0.87 | 1.08 |
Debt / FCF Ratio | 0.64 | 0.90 | 4.63 | - | 0.87 | - |
Net Debt / Equity Ratio | -0.09 | -0.06 | -0.01 | -0.02 | -0.25 | -0.09 |
Net Debt / EBITDA Ratio | -1.35 | -1.25 | -0.06 | -0.08 | -1.61 | -0.69 |
Net Debt / FCF Ratio | -0.71 | -0.48 | -0.27 | 0.26 | -1.27 | 10.99 |
Asset Turnover | 0.91 | 0.91 | 1.17 | 1.12 | 1.07 | 1.19 |
Inventory Turnover | 2.84 | 2.55 | 2.76 | 2.56 | 2.57 | 2.66 |
Quick Ratio | 1.04 | 1.04 | 0.89 | 0.87 | 1.01 | 1.13 |
Current Ratio | 1.60 | 1.60 | 1.39 | 1.44 | 1.49 | 1.71 |
Return on Equity (ROE) | 1.63% | 1.59% | 8.84% | 15.94% | 11.21% | 6.08% |
Return on Assets (ROA) | 0.47% | -0.06% | 4.14% | 5.60% | 3.81% | 3.38% |
Return on Invested Capital (ROIC) | 0.76% | -0.15% | 7.63% | 14.50% | 10.75% | 8.88% |
Return on Capital Employed (ROCE) | 1.20% | -0.10% | 10.00% | 13.90% | 9.00% | 7.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.21% | 3.98% | 11.85% | 14.62% | 12.78% | 7.48% |
FCF Yield | 25.11% | 33.24% | 5.07% | -6.08% | 23.56% | -1.07% |
Dividend Yield | - | - | 5.35% | 6.90% | 6.80% | - |
Payout Ratio | - | 222.96% | 24.30% | 71.35% | - | - |
Buyback Yield / Dilution | 2.42% | 2.60% | 0.18% | - | -1.20% | -0.98% |
Total Shareholder Return | 2.42% | 2.60% | 5.53% | 6.90% | 5.60% | -0.98% |